Burjeel Holdings Plc · ADX:BURJEEL

Burjeel — Q1 2026 Earnings Presentation

20 slides from Burjeel's earnings presentation, May 2026

  1. Slide 1: Q1 2026 Financial Results Earnings Presentation

    Q1 2026 Financial Results Earnings Presentation May 2026

  2. Slide 2: Disclaimer

    Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p

  3. Slide 3: Key Highlights

    Key Highlights Leading Super-Specialty Healthcare Provider in the GCC

  4. Slide 4: Q1'26 Results: Resilient Growth. Emerging Stronger.

    Q1’26 Results: Resilient Growth. Emerging Stronger. Key Highlights Defensive & Resilient Healthcare Platform Revenue AED 1,339m +5.1% YoY EBITDA Strong Operational Insured Proven Financial AED 201m Continuity Demand Resilience Position +11.2% YoY Net profit • All facilities • 100% insured • Delivere

  5. Slide 5: Recent Business Developments

    Recent Business Developments 41 20 Medical Hospitals Centers Expanding Network in High-Growth Locations Opened a new medical center in Dubai Silicon Oasis, enhancing access to integrated community-based healthcare services. 1,784 Beds Scaling Premium Aesthetics Platform Launched Tajmeel’s flagship c

  6. Slide 6: Recent Medical Developments

    Recent Medical Developments Delivering 20,860 Total Surgeries Da Vinci Xi Advancing Leadership in Complex Oncology 1,000 Robotic Surgeries Established a Neuro-Oncology Center at BMC integrating neurosurgery, oncology, radiation therapy, and advanced diagnostics to enhance complex cancer care capabil

  7. Slide 7: Reiterated Strategy: Anchoring the UAE Platform, Scaling Asset-Light Growth

    Reiterated Strategy: Anchoring the UAE Platform, Scaling Asset-Light Growth Across GCC & Beyond Targeted investments to expand the network while building scalable, Balanced capital allocation to capital-efficient platforms support sustainable growth UAE Expansion HealthTech Core Network Densificatio

  8. Slide 8: Performance Review

    Performance Review Leading Super-Specialty Healthcare Provider in the GCC

  9. Slide 9: Robust Patient Volume Growth Amid Evolving Market Conditions

    Robust Patient Volume Growth Amid Evolving Market Conditions Group Outpatient Footfall, k Group Inpatient Footfall, k % OP utilization • Total patient footfall increased 7.2% YoY to 1.8 % bed occupancy • Inpatient footfall increased 5.9% YoY, million in Q1, reflecting the strength of the demonstrati

  10. Slide 10: Resilient Revenue & EBITDA Growth Across Key Business Segments

    Resilient Revenue & EBITDA Growth Across Key Business Segments Group Revenue, AED m Group EBITDA, AED m Group EBITDA margin YoY • Total revenue grew by 5.1% YoY, supported YoY • Group EBITDA increased by 11.2% YoY, by 7.2% growth patient footfall, despite 14.2% 15.0% driven by lower inventory costs,

  11. Slide 11: Margin Normalization Progressing Through Asset Maturity & Cost Discipline

    Margin Normalization Progressing Through Asset Maturity & Cost Discipline Group OPEX Breakdown, % of Revenue Group EBITDA Analysis, AED m % EBITDA margin 1,098 1,134 14.2% 15.0% 86.2% 84.7% +30 (63) 175 +65 179 14.1% 13.1% (8) +4 (8) 39 47 3.5% 201 268 3.0% 181 298 23.4% 20.0% 582 644 48.1% 45.6% +1

  12. Slide 12: Strong Free Cash Flow Generation Along With Disciplined Capital Deployment

    Strong Free Cash Flow Generation Along With Disciplined Capital Deployment Net Cash from Operating Activities, AED m Total Investments, AED m % FCF conversion1 Growth CAPEX Maintenance CAPEX Acquisitions & Investments in Associates 66% 65% +18 23 (11) (4) (5) 161 72 33 +20 142 AED 201m AED 96m 59 10

  13. Slide 13: Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation

    Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation AED m 31 March 2026 31 December 2025 Debt Maturity as of 31 March 2026 Bank balances and cash 219 277 Interest-bearing loans and borrowings 1,853 1,918 526 Bank overdraft — — 414 346 340 Bank debt1 1,853 1,918 Net debt 1,634 1,

  14. Slide 14: Strong Profitability Momentum With Continued Commitment to Dividends

    Strong Profitability Momentum With Continued Commitment to Dividends Net Profit Analysis, AED m Commentary % net profit margin • Net profit increased by 44.5% YoY to 3.1% 4.2% AED 57 million in Q1’26, with net margins improving to 4.2% from +30 3.1% in Q1’25. This reflects strong operating performan

  15. Slide 15: Mid-Term Outlook & Guidance

    Mid-Term Outlook & Guidance Network Expansion Profitability 18 Healthcare Assets: 2 Hospitals — Dubai, 4 Day Surgery Centers — Group EBITDA margin expected to expand to the low-20s UAE, 6 Medical Centers — UAE, 2 Fertility Clinics — Al Ain and range on a blended basis, driven by asset ramp-up, scale

  16. Slide 16: Q&A

    Q&A Leading Super-Specialty Healthcare Provider in the GCC

  17. Slide 17: Q1'26 Financial Summary

    Q1’26 Financial Summary Group Income Statement Summary Financial Performance by Segment AED m Q1’26 Q1’25 AED m Q1’26 Q1’25 Revenue 1,339 1,274 Revenue 1,339 1,274 Hospitals1 1,188 1,126 Inventories consumed (268) (298) Medical Centers1 118 108 Doctors’ and other employees’ salaries (644) (582) Phar

  18. Slide 18: Q1'26 Financial Summary

    Q1’26 Financial Summary Balance Sheet Summary AED m 31 Mar 2026 31 Dec 2025 AED m 31 Mar 2026 31 Dec 2025 Non-current assets Shareholders' equity Share capital 521 521 Property and equipment 2,127 2,133 Shareholder’s contribution 4 4 Intangible assets 19 20 Other reserves 3 3 Right-of-use assets 1,0

  19. Slide 19: Q1'26 Financial Summary

    Q1’26 Financial Summary Cash Flow Summary AED, m Q1’26 Q1‘25 Change, % Operating activities Net Profit for the Period Before Tax 65 45 +46.0% Non-cash adjustments 201 183 +9.9% Working capital adjustments (69) (58) +19.3% Other (36) (27) +31.8% Net Cash, Operating activities 161 142 +13.1% Investing

  20. Slide 20: IR Contacts

    IR Contacts May 2026 Sergei Levitskii Director of Investor Relations Investor Feedback Hotline sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 Engaging openly with our investors and analysts is a cornerstone of our approach. We’ve partnered with Closir to make sharing your feedback quick and

Burjeel Holdings — Q1 2026 Earnings Presentation on 6ix